Are Infants Exposed to Methadone In Utero at an Increased Risk for Mortality?
May 1, 2012
Social Problem Solving in Children with Fetal Alcohol Spectrum Disorders
April 19, 2012
The Opioid Dependent Mother and Newborn- An Update. The 6th Annual Ivey Symposium
March 7, 2012
A Model for Estimating the Economic Impact of Fetal Alcohol Spectrum Disorder
February 25, 2012
An Exploration of the Experiences and Perspectives of New Zealanders with Fetal Alcohol Spectrum Disorder
February 5, 2012
Alcohol -Induced Behavioural Problems in Fetal Alcohol Spectrum Disorder Versus Confounding Behavioural Problems
January 10, 2012
Clinical Use of Meconium Fatty Acid Ethyl Esters for Identifying Children at Risk for Alcohol-Related Disabilities: The First Reported Case
January 10, 2012
When a Physician has Major Congenital Malformations
November 5, 2011
The Canary's Warning: Lessons from Patients with Spina Bifida
November 5, 2011
Meconium Testing for Fatty Acid Ethyl Esters: A 2011 Status Report
November 5, 2011
The Canadian Guidelines and the Interdisciplinary Clinical Capacity of Canada to Diagnose Fetal Alcohol Spectrum Disorder
October 16, 2011
An Analysis of Third Year Medical Students' Knowledge and Perceived Self-Efficacy to Counsel and Screen for Alcohol Use Among Pregnant Women
October 10, 2011
Feeling Different: The Experience of Living with Fetal Alcohol Spectrum Disorder
October 3, 2011
Legal and Ethical Considerations in Meconium Testing for Fetal Exposure to Alcohol
October 1, 2011
Review of: FASD Relationships - What I Have Learned from About Fetal Alcohol Spectrum Disorder
September 7, 2011
A Differential Approach for Examining the Behavioural Phenotype of Fetal Alcohol Research Disorders
September 5, 2011
A Need for Closer Examination of FASD by the Criminal Justice System: Has the Call Been Answered?
September 1, 2011
2011 Fetal Alcohol Canadian Expertise (FACE) Poster Competition Abstracts
September 1, 2011
Comparing Daily Living Skills in Adults with Fetal Alcohol Spectrum Disorder (FASD) to an IQ Matched Clinical Sample
July 29, 2011
Language Impairments in Children with Fetal Alcohol Spectrum Disorders
June 21, 2011
Alcohol Consumption During Pregnancy Among Women in Israel
May 10, 2011
Understanding Fetal Alcohol Spectrum Disorder - Bringing Schools and Teachers on Board
May 2, 2011
Canadian Palpebral Fissure Length Growth Charts Reflect a Good Fit for Two School and FASD Clinic-Based U.S. Populations
April 8, 2011
Executive Functioning and Working Memory Deficits on the CANTAB Among Children with Prenatal Alcohol Exposure
January 28, 2011
Reinforcement Learning in Children with Fetal Alcohol Spectrum Disorder
January 28, 2011
Training Needs of Healthcare Providers Related to Centers for Disease Control and Prevention Core Competencies for Fetal Alcohol Spectrum Disorders
November 1, 2010
Role of Central Nervous System Insulin Resistance in Fetal Alcohol Spectrum Disorders
October 26, 2010
A Long Journey: Biological and Non-Biological Parents' Experiences Raising Children with FASD
August 20, 2010
Drinking Alcohol during Pregnancy: Evidence from Canadian Community Health Survey 2007/2008
August 17, 2010
2010 FACE Poster Competition Abstracts
August 12, 2010
Reviewers' Bias Against the Null Hypothesis: the Reproductive Hazard of Binge Drinking
July 20, 2010
The Motherisk Alcohol and Substance Use Helpline: 10 Years of Experience and Counting
June 30, 2010
A Review of Substance Abuse Monitoring in a Social Services Context: A Primer for Child Protection Workers
April 15, 2010
The Impact of an ADHD Co-Morbidity on the Diagnosis of FASD
April 6, 2010
Normal Distribution of Palpebral Fissure Lengths in Canadian School Age Children
February 10, 2010
Managing Fetal Alcohol Spectrum Disorder in the Public School System: A Needs Assessment Pilot
February 10, 2010
Alcohol Content in Declared Non - or Low Alcoholic Beverages: Implications to Pregnancy
January 4, 2010
Motherisk Drug Testing Newsletter for Children's Aid Societies
December 2009
Estimating the Neurocognitive Effects of an Early Intervention Program for
Children with Prenatal Alcohol Exposure
November 19, 2009
Physical and Neurodevelopmental Evaluation of Children Adopted from Eastern
Europe
October 29, 2009
The Relation between Theory of Mind and Executive Functions in Children with
Fetal Alcohol Spectrum Disorders
July 26, 2009
Screening and Recording of Alcohol Use Among Women of Child-Bearing Age and
Pregnant Women
April 16, 2009
Concordance of Three Methods for Palpebral Fissure Length Measurement in the
Assessment of Fetal Alcohol Spectrum Disorder
April 16, 2009
Child Guardianship in a Canadian Home Visitation Program for Women who use
Substances in the Perinatal Period
January 30, 2009
The Burden of Prenatal Exposure to Alcohol: Revised Measurement of Cost
January 23, 2009
Costs of Fetal Alcohol Spectrum Disorder in Alberta, Canada
January 16, 2009
Gender and attention deficits in children diagnosed with a Fetal Alcohol Spectrum
Disorder
October 24, 2008
Development of Canadian Screening Tools for Fetal Alcohol Spectrum
Disorder
September 5, 2008
2008 FACE Poster Competition Abstracts September 9, 2008 Montreal, Quebec
August 19, 2008
Knowledge and Attitudes of Criminal Justice Professionals in Relation to Fetal
Alcohol Spectrum Disorder
August 4, 2008
Building Clinical Capacity for Fetal Alcohol Spectrum Disorder Diagnoses in
Western and Northern Canada
June 10, 2008
Fetal Alcohol Spectrum Disorder: New Zealand Birth Mothers' Experiences
June 1, 2008
What human service professionals know and want to know about fetal alcohol
syndrome
February 26, 2008
Fetal alcohol syndrome disorder pilot media intervention in New Jersey
February 26, 2008
Perspectives of mothers with substance use problems on father involvement
February 1, 2008
Fetal alcohol syndrome related knowledge assessment and comparison in New Jersey
health professional groups
January 9, 2008
Memory patterns of acquisition and retention of verbal and nonverbal information
in children with fetal alcohol spectrum disorders
January 9, 2008
POSTER COMPETITION ABSTRACTS
September 7, 2007
Hearing in Children With Fetal Alcohol Spectrum Disorder (FASD)
November 1, 2007
Rural FASD Diagnostic Services Model: Lakeland Centre for Fetal Alcohol Spectrum
Disorder
November 1, 2007
On November 1, 2007, the Journal of FAS International - JFAS Int - was amalgamated with the Canadian Journal of Clinical Pharmacology, a peer-review, on-line journal @ www.cjcp.ca. The Section in the amalgamated Journal dedicated to FASD is called Fetal Alcohol Research (FAR). This amalgamation will ensure that original research published in CJCP/FAR will be cited in PubMed - Medline, hence increasing the exposure of new findings in fetal alchol research within the scientific community.
Past issues of the Journal of FAS International will be maintained in the JFAS archives. You may view them any time. We will also continue to post the FACE Research Roundtable Webcasts, Scientific News andConferences and Events notices @ http://www.motherisk.org/FAR. So keep that page bookmarked.
FASD is the most prevalent cause of developmental delay and brain insult. Affecting an estimated 0.3% to 1% of all offspring, victims of FASD face debilitating, and often devastating effects that last a lifetime. Unlike other developmental brain impairment,the etiology of FASD is known. Yet progress in prevention, diagnosis and management has been painfully slow. Many factors need to be addressed, including the role of poverty, homelessness, psychiatric morbidity, social disparity, other drugs of abuse, poor nutrition and lack of medical care during pregnancy. It is our hope that this new journal and on-line resource will advance the search for new knowledge and solutions.
The amalgamated CJCP/FAR will continue to be web-based and freely available to clinicians, researchers, teachers, individuals affected by FASD (including parents, partners, siblings), program providers, community leaders and the public at large. We hope you find the content and format of Fetal Alcohol Research (FAR) useful in your practice, research and programs. We welcome your ideas about how to improve FAR and invite you to submit papers and letters.
Cordially,
Gideon Koren, MD, FABMT, FRCPC
Director, The Motherisk Program
Professor of Paediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics, The University of Toronto
Senior Scientist, The Research Institute, The Hospital for Sick Children, Toronto, Canada
The Ivey Chair in Molecular Toxicology, University of Western Ontario, Canada
* - "MOTHERISK - Treating the mother - Protecting the unborn" is an official mark of The Hospital for Sick Children. All rights reserved.
The information on this website is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and before you take any medications.
Copyright © 1999-2012 The Hospital for Sick Children (SickKids). All rights reserved.
The Hospital for Sick Children (SickKids) is a health-care, teaching and research centre dedicated exclusively to children; affiliated with the University of Toronto. For general inquires please call: 416-813-1500.